Presently, Pepinemab has entered clinical development for patients with solid tumors (NCT01313065, NCT03268057) and neurodegenerative diseases, including early Huntingtons disease and Alzheimers disease (NCT02481674, NCT04381468), demonstrating a favorable safety profile 78,79,80,81
If you reside within the European Economic Area (EEA), our processing of your personal data will be justified if one of the following conditions is satisfied: Whenever we obtain your consent
Options include resealable packs, plastic or glass boxes, and specially designed tobacco humidors
Nicorette Inhalers for Quitting Smoking An essential tool in NRT is the Nicorette inhaler, which delivers a controlled amount of nicotine vapor to help alleviate cravings and withdrawal symptoms
Barreiro, E., Gea, J., Matar, G